Treatment-resistant recurrent membranoproliferative glomerulonephritis in renal allograft responding to rituximab: case report

scientific article published on April 2015

Treatment-resistant recurrent membranoproliferative glomerulonephritis in renal allograft responding to rituximab: case report is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TRANSPROCEED.2015.02.003
P698PubMed publication ID25891740
P5875ResearchGate publication ID275038243

P2093author name stringM Farooqui
H Alhamdan
K Alsaad
N Aloudah
P2860cites workResponse of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapyQ71951418
Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS)Q72829904
Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: analysis of the incidence, risk factors, and impact on graft survivalQ73445498
Frequency of primary glomerular disease in northeastern ChinaQ84583966
Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recoveryQ84654866
Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature reviewQ31039549
Pattern of biopsy-proven renal disease in a single center of south India: 19 years experienceQ35351264
Glomerular diseases in the Military Hospital of Morocco: Review of a single centre renal biopsy database on adults.Q36391014
Posttransplant recurrence of primary glomerulonephritisQ37804640
Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature.Q38026511
Clinicopathological features of childhood nephrotic syndrome in Saudi ArabiaQ38856560
Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosisQ40144637
Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphomaQ40409474
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).Q41693630
Combination therapy with mycophenolate mofetil and prednisone in steroid-resistant idiopathic membranoproliferative glomerulonephritis.Q43085129
Prognostic factors in mesangioproliferative glomerulonephritisQ44116235
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.Q44726792
Remission of resistant MPGN type I with mycophenolate mofetil and steroidsQ45084031
Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experienceQ46486094
Rituximab therapy for Type I membranoproliferative glomerulonephritis.Q51395552
Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritisQ59644719
Membranoproliferative Glomerulonephritis Type I in Renal Transplantation Patients: A Single-Center Study of a Cohort of 68 Renal Transplants Followed Up for 11 YearsQ60729392
Recurrent membranoproliferative glomerulonephritis after kidney transplantationQ60976642
Effectiveness of pulse cyclophosphamide plus oral steroid therapy in idiopathic membranoproliferative glomerulonephritisQ62085808
Results of a controlled drug trial in membranoproliferative glomerulonephritisQ69889953
Pulse methylprednisolone therapy in children with membranoproliferative glomerulonephritisQ70816465
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmembranoproliferative glomerulonephritisQ2299379
rituximabQ412323
glomerulonephritisQ605006
P304page(s)823-826
P577publication date2015-04-01
P1433published inTransplantation ProceedingsQ7834825
P1476titleTreatment-resistant recurrent membranoproliferative glomerulonephritis in renal allograft responding to rituximab: case report
P478volume47

Reverse relations

cites work (P2860)
Q39009557Chronic allograft injury: Mechanisms and potential treatment targets
Q38795065Current pathological perspectives on chronic rejection in renal allografts
Q48256943Diseases of complement dysregulation-an overview
Q93047764Recurrent and de novo Glomerulonephritis After Kidney Transplantation
Q38749694Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies

Search more.